comparemela.com
Home
Live Updates
Photodynamic Compounds - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Photodynamic compounds - Page 1 : comparemela.com
Theralase Releases Q222 Interim Financial Statements
TORONTO, Aug. 29, 2022 (GLOBE NEWSWIRE) Theralase
United states
Arkady mandel
Vera madzarevic
Company photo dynamic compounds
Good laboratory practices
Collaborative research agreement
Development expenses
Technologies inc
Public health agency of canada
Postmedia network inc
National microbiology laboratory
Venture exchange
Regulation services provider
Financial statements
Photodynamic compounds
Postmedia network
Theralase Releases Q122 Interim Financial Statements
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
United states
Company photo dynamic compounds
Good laboratory practices
Collaborative research agreement
Development expenses
Technologies inc
Public health agency of canada
National microbiology laboratory
Venture exchange
Regulation services provider
Photodynamic compounds
Financial statements
Consolidated statements
Through designation
Fast track designation
Fast track
Theralase Releases Q122 Interim Financial Statements
TORONTO, May 30, 2022 (GLOBE NEWSWIRE) Theralase ® Technologies Inc. (“ Theralase ” or the “ Company ”) ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage…
United states
Company photo dynamic compounds
Good laboratory practices
Collaborative research agreement
Development expenses
Technologies inc
Public health agency of canada
Postmedia network inc
National microbiology laboratory
Venture exchange
Regulation services provider
Financial statements
Photodynamic compounds
Consolidated statements
Through designation
Fast track designation
Theralase Release FY2021 Audited Financial Statements
TORONTO, April 29, 2022 (GLOBE NEWSWIRE) Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage.
Technologies inc
Photodynamic compounds
Consolidated statements
Tsx venture exchange tlt
Theralase technologies inc
Cancer research
Bladder cancer
Theralase Releases Q12021 Interim Financial Statements
TORONTO, May 28, 2021 (GLOBE NEWSWIRE) Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage…
United states
Good laboratory practices
Collaborative research agreement
Development expenses
Technologies inc
Public health agency of canada
National microbiology laboratory
Venture exchange
Regulation services provider
Photodynamic compounds
Consolidated statements
Therapeutic dose
Study treatment
Breakthrough designation
Glio blastoma multiforme
Non small cell lung cancer
vimarsana © 2020. All Rights Reserved.